↓ Skip to main content

Research and Development Costs for New Drugs by Therapeutic Category

Overview of attention for article published in PharmacoEconomics, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

blogs
1 blog
policy
2 policy sources

Citations

dimensions_citation
155 Dimensions

Readers on

mendeley
49 Mendeley
Title
Research and Development Costs for New Drugs by Therapeutic Category
Published in
PharmacoEconomics, November 2012
DOI 10.2165/00019053-199507020-00007
Pubmed ID
Authors

Joseph A. DiMasi, Ronald W. Hansen, Henry C. Grabowski, Louis Lasagna

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 4%
Unknown 47 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 22%
Student > Ph. D. Student 9 18%
Student > Master 7 14%
Student > Bachelor 5 10%
Student > Doctoral Student 3 6%
Other 10 20%
Unknown 4 8%
Readers by discipline Count As %
Business, Management and Accounting 9 18%
Pharmacology, Toxicology and Pharmaceutical Science 7 14%
Agricultural and Biological Sciences 6 12%
Economics, Econometrics and Finance 5 10%
Chemistry 5 10%
Other 11 22%
Unknown 6 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2018.
All research outputs
#3,121,464
of 25,373,627 outputs
Outputs from PharmacoEconomics
#294
of 1,992 outputs
Outputs of similar age
#21,837
of 192,216 outputs
Outputs of similar age from PharmacoEconomics
#33
of 383 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,992 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,216 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 383 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.